EPIC PODCAST
In Episode 2 of Innovations in Cancer, we speak with Lauren Leiman, executive director at BloodPAC, the Blood Profiling Atlas in Cancer (BloodPAC) Consortium, launched October 2017, to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. Lauren discusses the collaborative infrastructure that enables sharing of information between stakeholders in industry, academia, and regulatory agencies with the goal to standardize liquid biopsies to improve outcomes for patients.
Listen NowIn this first episode of Innovations in Cancer, we spoke with Bryce Olson, who was diagnosed with advanced prostate cancer at 44 years old. His google searches showed a grim prognosis of one year. Five years later, Bryce is active and continuing his passion for surfing.
Listen Now